Earnings Call · Q4 FY2024·2025-03-10

Q4 24EPS +66.67%·Rev n/aQ3 24EPS +33.33%·Rev n/aQ2 24EPS +25.00%·Rev n/aQ1 24EPS 0.00%·Rev n/a⚠ consensus missing

Lineage Cell Therapeutics, Inc. LCTX

Ioana Hone — Investor Relations

Brian Culley — Chief Executive Officer

Jill Howe — Chief Financial Officer

+1.1%1d on move date+3.7% vs SPY3d−1.0%5d−1.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LCTX calls or request research access.

More LCTX calls Browse calls Request research access